Steven Moss is a physician-scientist whose research focuses on the pathogenesis and management of H. pylori infection. He is a clinical gastroenterologist at Brown University Health and Providence VA Medical Center and former Director of the Brown Gastroenterology Fellowship Training Program.
| Quach DT, Liou JM, Gisbert JP, Leung WK, Moss SF, Fallone CA, Katelaris P, Schulz C, Kayamba V, Zhou L, Vu NTH, Vilaichone RK, Miftahussurur M, Setshedi M, Riquelme A, Yadegar A, Lee YY, Ishibashi F, Jung HY, Coelho LG, Suzuki H, Lee YC, Megraud F, Mahachai V, Sugano K, Malfertheiner P. "Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice." Aliment Pharmacol Ther, vol. 64, no. 3, 2026, pp. 308-312. |
| Rajadurai S, Moss SF. "Editorial: H. pylori Antimicrobial Susceptibility Testing-An Expanding Toolbox." Aliment Pharmacol Ther, vol. 61, no. 3, 2025, pp. 579-580. |
| Wadhavkar N, Varnum L, Moss SF. "High Economic Burden Yet Low Clinical Value: Why Is so Much Sucralfate Prescribed?." Basic & clinical pharmacology & toxicology, vol. 137, no. 1, 2025, pp. e70070. |
| Bush DM, Kohia S, Garcia Hernandez A, Siota S, Wore E, Jagilly R, Melly A, Katelaris PH, Norrie MW, Martiniuk AL, Moss SF. "Upper endoscopy in Solomon Islands: A four-year retrospective study." Science progress, vol. 108, no. 3, 2025, pp. 368504251355383. |
| Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, Shah SC. "ACG Clinical Guideline: Treatment of Helicobacter pylori Infection." American Journal of Gastroenterology, vol. 119, no. 9, 2024, pp. 1730-1753. |
| Moss SF, Shah SC, Tan MC, El-Serag HB. "Evolving Concepts in Helicobacter pylori Management." Gastroenterology, vol. 166, no. 2, 2024, pp. 267-283. |
| Andrews CB, Herzlinger MI, Moss SF. "Helicobacter pylori Antimicrobial Resistance and the Role of Next-Generation Sequencing." Gastroenterology & hepatology, vol. 20, no. 8, 2024, pp. 469-476. |
| Tazinkeng N, Monteiro JF, Mbianyor BE, Nowbuth AA, Ntonifor M, Evenge C, Nkhoma A, Moss SF, Asombang AW. "Knowledge and approach towards Helicobacter pylori diagnosis and management among primary care physicians in Cameroon: a cross-sectional study." Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 118, no. 5, 2024, pp. 313-320. |
| Moss SF, Chey WD, Daniele P, Pelletier C, Jacob R, Tremblay G, Hubscher E, Leifke E, Malfertheiner P. "Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of Helicobacter pylori infection." Therapeutic advances in gastroenterology, vol. 16, 2023, pp. 17562848231167284. |
| Riaz MS, Moss SF, Shapiro JM, Cerezo C, Herzlinger M. "Diagnostic and Treatment Practices for Helicobacter Pylori Infection in an Academic Pediatric Hospital." Rhode Island medical journal (2013), vol. 106, no. 6, 2023, pp. 35-39. |
| Sugano K, Moss SF, Kuipers EJ. "Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer?." Gastroenterology, vol. 165, no. 6, 2023, pp. 1352-1366.e1. |
| Tse CS, Hinds S, Nguyen H, Xiong N, Moss SF, Bhagra A. "A 12-Year North American Longitudinal Study of Gender Equity and Equality in Gastroenterology." Gastroenterology, vol. 162, no. 1, 2022, pp. 63-67. |
| Graham DY, Moss SF. "Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why." American Journal of Gastroenterology, vol. 117, no. 4, 2022, pp. 524-528. |
| Argueta EA, Ho JJC, Elfanagely Y, D'Agata E, Moss SF. "Clinical Implication of Drug Resistance for H. pylori Management." Antibiotics, vol. 11, no. 12, 2022. |
| Moss SF, Dang LP, Chua D, Sobrado J, Zhou Y, Graham DY. "Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation Sequencing." Gastroenterology, vol. 162, no. 7, 2022, pp. 2095-2097.e2. |
| Ho JJC, Navarro M, Sawyer K, Elfanagely Y, Moss SF. "Helicobacter pylori Antibiotic Resistance in the United States Between 2011-2021: A Systematic Review and Meta-Analysis." American Journal of Gastroenterology, 2022. |
| Ho JJC, Argueta EA, Moss SF. "Helicobacter pylori Treatment Regimens: A US Perspective." Gastroenterology & hepatology, vol. 18, no. 6, 2022, pp. 313-319. |
| Argueta, Erick A., Moss, Steven F. "How We Approach Difficult to Eradicate Helicobacter pylori." Gastroenterology, vol. 162, no. 1, 2022, pp. 32-37. |
| Shah SC, Iyer PG, Moss SF. "AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review." Gastroenterology, vol. 160, no. 5, 2021, pp. 1831-1841. |
| Elfanagely Y, Atsawarungruangkit A, Scharfen J, Pavlech L, Moss SF. "Association Between Obstructive Sleep Apnea and Barrett's Esophagus: A Systematic Review and Meta-Analysis." Digestive Diseases and Sciences, vol. 66, no. 11, 2021, pp. 3689-3697. |
| Cho J, Prashar A, Jones NL, Moss SF. "Helicobacter pylori Infection." Gastroenterology clinics of North America, vol. 50, no. 2, 2021, pp. 261-282. |
| Argueta EA, Alsamman MA, Moss SF, D'Agata EMC. "Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population." Gastroenterology, vol. 160, no. 6, 2021, pp. 2181-2183.e1. |
| Argueta, Erick A., Moss, Steven F. "The prevention of gastric cancer by Helicobacter pylori eradication." Current Opinion in Gastroenterology, vol. 37, no. 6, 2021, pp. 625-630. |
| Argueta EA, Moss SF. "The prevention of gastric cancer by Helicobacter pylori eradication." Current Opinion in Gastroenterology, vol. 37, no. 6, 2021, pp. 625-630. |
| Elfanagely, Yousef, Atsawarungruangkit, Amporn, Moss, Steven F. "Understanding GI Twitter and Its Major Contributors." Gastroenterology, vol. 160, no. 6, 2021, pp. 1917-1921. |
| Atsawarungruangkit, Amporn, Yuan, Jin, Kodama, Takamitsu, Cheng, Ming-Tai, Mansouri, Mohammad, Han, Boram, Kongkamnerd, Jarinrat, Riegg, Fabian, Menon, Anupama, Moss, Steven F. "Evolving global and national criteria for identifying a suspected case of COVID-19." Journal of International Medical Research, vol. 48, no. 8, 2020, pp. 030006052093894. |
| Rebello, Dionne. "Heparin bridge is associated with more post-polypectomy bleeding and emergency department visits among anticoagulated patients." Annals of Gastroenterology, vol. 33, no. 1, 2020, pp. 73-79. |
| Argueta EA, Moss SF. "Management of Helicobacter pylori." Current Opinion in Gastroenterology, vol. 36, no. 6, 2020, pp. 518-524. |
| Ruddell JH, Eltorai AEM, Bakhit M, Lateef AM, Moss SF. "Analysis of Accredited Gastroenterology Fellowship Internet-Available Content: Twenty-Nine Steps Toward a Better Program Website." Digestive Diseases and Sciences, vol. 64, no. 5, 2019, pp. 1074-1078. |
| Argueta EA, Moss SF. "Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment." Aliment Pharmacol Ther, vol. 50, no. 3, 2019, pp. 331-332. |
| Fallone CA, Moss SF, Malfertheiner P. "Helicobacter pylori Infection." New England Journal of Medicine, vol. 381, no. 6, 2019, pp. 588. |
| Fallone CA, Moss SF, Malfertheiner P. "Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics." Gastroenterology, vol. 157, no. 1, 2019, pp. 44-53. |
| Alsamman MA, Vecchio EC, Shawwa K, Acosta-Gonzales G, Resnick MB, Moss SF. "Retrospective Analysis Confirms Tetracycline Quadruple as Best Helicobacter pylori Regimen in the USA." Digestive Diseases and Sciences, vol. 64, no. 10, 2019, pp. 2893-2898. |
| Shirin H, Richter V, Matalon S, Abramowich D, Maliar A, Shachar E, Moss SF, Broide E. "Safety, tolerability and efficacy of a novel self-use biodegradable device for management of obesity." Obesity science & practice, vol. 5, no. 4, 2019, pp. 376-382. |
| Richter V, Gonzalez JO, Hazan S, Gottlieb G, Friedenberg K, Gatof D, Ganeshappa R, Delgado JS, Abramowitz D, Hardi R, Coates A, Haq M, Mehta N, Jones BA, Moss SF, Shirin H. "The validity of breath collection bags method in detecting <i>Helicobacter pylori</i> using the novel <i>BreathID</i> <sup>®</sup> <i>Hp Lab System</i>: a multicenter clinical study in 257 subjects." Therapeutic advances in gastrointestinal endoscopy, vol. 12, 2019, pp. 2631774519843401. |
| Argueta EA, Moss SF. "Treatment of Helicobacter pylori." Current Opinion in Gastroenterology, vol. 35, no. 6, 2019, pp. 544-550. |
| Simons, Malorie, Scott-Sheldon, Lori A.J., Risech-Neyman, Yesenia, Moss, Steven F., Ludvigsson, Jonas F., Green, Peter H.R. "Celiac Disease and Increased Risk of Pneumococcal Infection: A Systematic Review and Meta-Analysis." The American Journal of Medicine, vol. 131, no. 1, 2018, pp. 83-89. |
| Chey, William D., Leontiadis, Grigorios I., Howden, Colin W., Moss, Steven F. "Correction: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection." The American Journal of Gastroenterology, vol. 113, no. 7, 2018, pp. 1102. |
| Siddique O, Moss SF. "Editorial: Helicobacter pylori resistance and sequential therapy." Aliment Pharmacol Ther, vol. 48, no. 1, 2018, pp. 95-96. |
| Siddique O, Ovalle A, Siddique AS, Moss SF. "Helicobacter pylori Infection: An Update for the Internist in the Age of Increasing Global Antibiotic Resistance." The American Journal of Medicine, vol. 131, no. 5, 2018, pp. 473-479. |
| El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, Crowe S, Elfant A, Haas T, Hapke RJ, Graham DY. "Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States." Clinical Gastroenterology and Hepatology, vol. 16, no. 7, 2018, pp. 992-1002.e6. |
| Pellicano R, Zagari RM, Zhang S, Saracco GM, Moss SF. "Pharmacological considerations and step-by-step proposal for the treatment of Helicobacter pylori infection in the year 2018." Minerva gastroenterologica e dietologica, 2018. |
| Chey, William D, Leontiadis, Grigorios I, Howden, Colin W, Moss, Steven F. "Response to Hsu et al." The American Journal of Gastroenterology, vol. 113, no. 1, 2018, pp. 143-143. |
| Iqbal U, Siddique O, Ovalle A, Anwar H, Moss SF. "Safety and efficacy of a minimally invasive cell sampling device ('Cytosponge') in the diagnosis of esophageal pathology: a systematic review." European Journal of Gastroenterology & Hepatology, vol. 30, no. 11, 2018, pp. 1261-1269. |
| Chey WD, Leontiadis GI, Howden CW, Moss SF. "ACG Clinical Guideline: Treatment of Helicobacter pylori Infection." American Journal of Gastroenterology, vol. 112, no. 2, 2017, pp. 212-239. |
| Zhang, Songhua, Moss, Steven F. "Cell recruitment in gastric carcinogenesis." Aging, vol. 9, no. 1, 2017, pp. 1-2. |
| Alzahrani, Saud, Nelson, Jason, Moss, Steven F., Paulus, Jessica K., Knowler, William C., Pittas, Anastassios G. "H. pylori seroprevalence and risk of diabetes: An ancillary case–control study nested in the diabetes prevention program." Journal of Diabetes and its Complications, vol. 31, no. 10, 2017, pp. 1515-1520. |
| Broide E, Richter V, Mendlovic S, Shalem T, Eindor-Abarbanel A, Moss SF, Shirin H. "Lymphoid follicles in children with <i>Helicobacter pylori</i>-negative gastritis." Clinical and Experimental Gastroenterology, vol. 10, 2017, pp. 195-201. |
| Broide, Efrat, Richter, Vered, Mendlovic, Sonia, Shalem, Tzippora, Eindor-Abarbanel, Adi, Moss, Steven, Shirin, Haim. "Lymphoid follicles in children with Helicobacter pylori-negative gastritis." Clinical and Experimental Gastroenterology, vol. Volume 10, 2017, pp. 195-201. |
| Chey, William D, Leontiadis, Grigorios I, Howden, Colin W, Moss, Steven F. "Response to Georgopoulos et al." The American Journal of Gastroenterology, vol. 112, no. 7, 2017, pp. 1169-1170. |
| Chey WD, Leontiadis GI, Howden CW, Moss SF. "Response to Georgopoulos et al." American Journal of Gastroenterology, vol. 112, no. 7, 2017, pp. 1169-1170. |
| Ouseph MM, Simons M, Treaba DO, Yakirevich E, Green PH, Bhagat G, Moss SF, Mangray S. "Fatal <i>Streptococcus pneumoniae</i> Sepsis in a Patient With Celiac Disease-Associated Hyposplenism." ACG Case Reports Journal, vol. 3, no. 4, 2016, pp. e140. |
| Zhang S, Kim W, Pham TT, Rogers AB, Houghton JM, Moss SF. "Native and bone marrow - derived cell mosaicism in gastric carcinoma in H. pylori - infected p27-deficient mice." Oncotarget, vol. 7, no. 43, 2016, pp. 69136-69148. |
| Simons M, Ferreira J, Meunier R, Moss S. "Primary versus Metastatic Gastrointestinal Melanoma: A Rare Case and Review of Current Literature." Case reports in gastrointestinal medicine, vol. 2016, 2016, pp. 2306180. |
| Moss SF. "The Clinical Evidence Linking <i>Helicobacter pylori</i> to Gastric Cancer." Cellular and molecular gastroenterology and hepatology, vol. 3, no. 2, 2016, pp. 183-191. |
| Levin, Scott R, Ziud, Hassan, Jimoh, Olanrewaju Y, Tseng, Yun-An, Robinson-Bostom, Leslie, Moss, Steven F. "Ulcerative Colitis Presenting With Palmoplantar Neutrophilic Dermatosis." Am J Gastroenterol, vol. 111, no. 7, 2016, pp. 923-923. |
| Lee, Raymond T., Ferreira, Jason, Friedman, Kenneth, Moss, Steven F. "A rare cause of constipation: obstructing small cell neuroendocrine carcinoma of the anal canal." International Journal of Colorectal Disease, vol. 30, no. 9, 2015, pp. 1291-1292. |
| Lee RT, Ferreira J, Friedman K, Moss SF. "A rare cause of constipation: obstructing small cell neuroendocrine carcinoma of the anal canal." International Journal of Colorectal Disease, vol. 30, no. 9, 2015, pp. 1291-2. |
| Oberg K, Modlin IM, De Herder W, Pavel M, Klimstra D, Frilling A, Metz DC, Heaney A, Kwekkeboom D, Strosberg J, Meyer T, Moss SF, Washington K, Wolin E, Liu E, Goldenring J. "Consensus on biomarkers for neuroendocrine tumour disease." The Lancet Oncology, vol. 16, no. 9, 2015, pp. e435-e446. |
| Zhang, Songhua, Lee, Dong Soo, Morrissey, Rhiannon, Aponte-Pieras, Jose R., Rogers, Arlin B., Moss, Steven F. "Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model." Cancer Letters, vol. 359, no. 2, 2015, pp. 345-351. |
| Zhang S, Lee DS, Morrissey R, Aponte-Pieras JR, Rogers AB, Moss SF. "Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model." Cancer Letters, vol. 359, no. 2, 2015, pp. 345-51. |
| Zhang, Songhua, Lee, Dong Soo, Morrissey, Rhiannon, Aponte-Pieras, Jose R., Rogers, Arlin B., Moss, Steven F. "Erratum to ‘Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model’ [Cancer Lett. 355 (1) (2014) 106–112]." Cancer Letters, vol. 359, no. 2, 2015, pp. 344. |
| Dalal RS, Moss SF. "At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer." Journal of Leukocyte Biology, vol. 96, no. 2, 2014, pp. 213-24. |
| Ferreira J, Moss SF. "Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection." Current treatment options in gastroenterology, vol. 12, no. 4, 2014, pp. 373-84. |
| Zhang S, Lee DS, Morrissey R, Aponte-Pieras JR, Rogers AB, Moss SF. "Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model." Cancer Letters, vol. 355, no. 1, 2014, pp. 106-12. |
| Moss SF. "How Can We Rationally Select Helicobacter pylori Therapy Without Resistance Data?." Clinical Gastroenterology and Hepatology, vol. 12, no. 9, 2014, pp. 1578. |
| Zhang S, Desrosiers J, Aponte-Pieras JR, DaSilva K, Fast LD, Terry F, Martin WD, De Groot AS, Moise L, Moss SF. "Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods." PLoS ONE, vol. 9, no. 4, 2014, pp. e94974. |
| Olefson, Sidney, Moss, Steven F. "Obesity and related risk factors in gastric cardia adenocarcinoma." Gastric Cancer, vol. 18, no. 1, 2014, pp. 23-32. |
| Nisimova, Liana, Wen, Sicheng, Cross-Knorr, Sam, Rogers, Arlin B., Moss, Steven F., Chatterjee, Devasis. "Role of Raf Kinase Inhibitor Protein in Helicobacter pylori-Mediated Signaling in Gastric Cancer." Critical Reviews in Oncogenesis, vol. 19, no. 6, 2014, pp. 469-481. |
| Nisimova L, Wen S, Cross-Knorr S, Rogers AB, Moss SF, Chatterjee D. "Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer." Critical Reviews in Oncogenesis, vol. 19, no. 6, 2014, pp. 469-81. |
| Zandman D, Hahn W, Moss S. "A Case of Persistent Helicobacter pylori Infection Occurring with Anti-IgE Immunosuppression." ACG Case Reports Journal, vol. 1, no. 1, 2013, pp. 16-8. |
| Tang X, Wen S, Zheng D, Tucker L, Cao L, Pantazatos D, Moss SF, Ramratnam B. "Acetylation of drosha on the N-terminus inhibits its degradation by ubiquitination." PLoS ONE, vol. 8, no. 8, 2013, pp. e72503. |
| Cao W, Tian W, Hong J, Li D, Tavares R, Noble L, Moss SF, Resnick MB. "Expression of bile acid receptor TGR5 in gastric adenocarcinoma." American journal of physiology. Gastrointestinal and liver physiology, vol. 304, no. 4, 2013, pp. G322-7. |
| Koch M, Meyer TF, Moss SF. "Inflammation, immunity, vaccines for Helicobacter pylori infection." Helicobacter, vol. 18 Suppl 1, 2013, pp. 18-23. |
| Moss SF. "The rediscovery of H. pylori bacteria in the gastric mucosa by Robin Warren, and implications of this finding for human biology and disease." Digestive Diseases and Sciences, vol. 58, no. 11, 2013, pp. 3072-8. |
| Byun SW, Chang YJ, Chung IS, Moss SF, Kim SS. "Helicobacter pylori decreases p27 expression through the delta opioid receptor-mediated inhibition of histone acetylation within the p27 promoter." Cancer Letters, vol. 326, no. 1, 2012, pp. 96-104. |
| Ruiz VE, Sachdev M, Zhang S, Wen S, Moss SF. "Isolating, immunophenotyping and ex vivo stimulation of CD4+ and CD8+ gastric lymphocytes during murine Helicobacter pylori infection." Journal of immunological methods, vol. 384, no. 1-2, 2012, pp. 157-63. |
| Moise L, Moss SF, De Groot AS. "Moving Helicobacter pylori vaccine development forward with bioinformatics and immunomics." Expert review of vaccines, vol. 11, no. 9, 2012, pp. 1031-3. |
| Wen S, So Y, Singh K, Slingerland JM, Resnick MB, Zhang S, Ruiz V, Moss SF. "Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer." Oncogene, vol. 31, no. 14, 2012, pp. 1771-80. |
| Moen EL, Wen S, Anwar T, Cross-Knorr S, Brilliant K, Birnbaum F, Rahaman S, Sedivy JM, Moss SF, Chatterjee D. "Regulation of RKIP function by Helicobacter pylori in gastric cancer." PLoS ONE, vol. 7, no. 5, 2012, pp. e37819. |
| Zhang S, Moss SF. "Rodent models of Helicobacter infection, inflammation, and disease." Methods in Molecular Biology, vol. 921, 2012, pp. 89-98. |
| Ardito M, Fueyo J, Tassone R, Terry F, DaSilva K, Zhang S, Martin W, De Groot AS, Moss SF, Moise L. "An Integrated Genomic and Immunoinformatic Approach to <i>H. pylori</i> Vaccine Design." Immunome research, vol. 7, no. 2, 2011. |
| Zhang S, Moise L, Moss SF. "H. pylori vaccines: why we still don't have any." Human vaccines, vol. 7, no. 11, 2011, pp. 1153-7. |
| Kim SS, Ruiz VE, Carroll JD, Moss SF. "Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma." Cancer Letters, vol. 305, no. 2, 2011, pp. 228-38. |
| Moss SF, Moise L, Lee DS, Kim W, Zhang S, Lee J, Rogers AB, Martin W, De Groot AS. "HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model." Vaccine, vol. 29, no. 11, 2011, pp. 2085-91. |
| Modlin IM, Moss SF, Gustafsson BI, Lawrence B, Schimmack S, Kidd M. "The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant." Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie, vol. 396, no. 8, 2011, pp. 1145-56. |
| Watson JB, Moss SF. "Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen." American Journal of Gastroenterology, vol. 106, no. 11, 2011, pp. 1976-7. |
| Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd M. "Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease." Annals of Surgical Oncology, vol. 17, no. 9, 2010, pp. 2427-43. |
| Modlin IM, Moss SF, Oberg K, Padbury R, Hicks RJ, Gustafsson BI, Wright NA, Kidd M. "Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management." The Medical journal of Australia, vol. 193, no. 1, 2010, pp. 46-52. |
| Huang BL, Rich HG, Simundson SE, Dhingana MK, Harrington C, Moss SF. "Intentional swallowing of foreign bodies is a recurrent and costly problem that rarely causes endoscopy complications." Clinical Gastroenterology and Hepatology, vol. 8, no. 11, 2010, pp. 941-6. |
| Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gönen M, Jensen RT, Kidd M, Kulke MH, Lloyd RV, Moran C, Moss SF, Oberg K, O'Toole D, Rindi G, Robert ME, Suster S, Tang LH, Tzen CY, Washington MK, Wiedenmann B, Yao J. "Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set." The American Journal of Surgical Pathology, vol. 34, no. 3, 2010, pp. 300-13. |
| Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, Tack J, Heading RC, Holtman G, Moss SF, Vevey NERD Consensus Group. "Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group." Digestion, vol. 80, no. 2, 2009, pp. 74-88. |
| Wen S, Moss SF. "Helicobacter pylori virulence factors in gastric carcinogenesis." Cancer Letters, vol. 282, no. 1, 2009, pp. 1-8. |
| McGowan CE, Saha S, Chu G, Resnick MB, Moss SF. "Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol." Southern Medical Journal, vol. 102, no. 5, 2009, pp. 493-7. |
| Vorlop E, Zaidman J, Moss SF. "Clinical challenges and images in GI. Downhill esophageal varices secondary to superior vena cava occlusion." Gastroenterology, vol. 135, no. 6, 2008, pp. 1863, 2158. |
| Wolff JH, Rubin A, Potter JD, Lattimore W, Resnick MB, Murphy BL, Moss SF. "Clinical significance of colonoscopic findings associated with colonic thickening on computed tomography: is colonoscopy warranted when thickening is detected?." Journal of clinical gastroenterology, vol. 42, no. 5, 2008, pp. 472-5. |
| Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, Westley BR, May FE, Gao J, Meitner PA, Tavares R, Resnick MB. "Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis." Clin Cancer Res , vol. 14, no. 13, 2008, pp. 4161-7. |
| Sabo E, Meitner PA, Tavares R, Corless CL, Lauwers GY, Moss SF, Resnick MB. "Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue." Clin Cancer Res , vol. 14, no. 20, 2008, pp. 6440-8. |
| Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. "Gastroenteropancreatic neuroendocrine tumours." The Lancet Oncology, vol. 9, no. 1, 2008, pp. 61-72. |
| Moise L, McMurry JA, Pappo J, Lee DS, Moss SF, Martin WD, De Groot AS. "Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori." Human vaccines, vol. 4, no. 3, 2008, pp. 219-23. |
| Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, Tack J, Holtmann G, Moss SF. "Non-erosive reflux disease--defining the entity and delineating the management." Digestion, vol. 78 Suppl 1, 2008, pp. 1-5. |
| Modlin IM, Moss SF, Chung DC, Jensen RT, Snyderwine E. "Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors." JNCI Journal of the National Cancer Institute, vol. 100, no. 18, 2008, pp. 1282-9. |
| Pellish RS, Nasir A, Ramratnam B, Moss SF. "Review article: RNA interference--potential therapeutic applications for the gastroenterologist." Aliment Pharmacol Ther, vol. 27, no. 9, 2008, pp. 715-23. |
| Modlin IM, Moss SF. "Symptom evaluation in gastroesophageal reflux disease." Journal of clinical gastroenterology, vol. 42, no. 5, 2008, pp. 558-63. |
| Moss SF, Malfertheiner P. "Helicobacter and gastric malignancies." Helicobacter, vol. 12 Suppl 1, 2007, pp. 23-30. |
| Lee DS, Moss SF. "Targeting Helicobacter pylori in gastric carcinogenesis." Expert Opinion on Therapeutic Targets, vol. 11, no. 6, 2007, pp. 757-69. |
| Hunt RH, Tytgat GH, Malfertheiner P, Fock KM, Heading RC, Katelaris PH, McCarthy DM, McColl KE, Moss SF, Sachs G, Sontag SJ, Thomson AB, Modlin IM. "Whistler summary: "the slow rate of rapid progress"." Journal of clinical gastroenterology, vol. 41, no. 6, 2007, pp. 539-45. |
| Kim SS, Meitner P, Konkin TA, Cho YS, Resnick MB, Moss SF. "Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol. 19, no. 1, 2006, pp. 49-58. |
| Lee DS, Moss SF. "COX-2 inhibition and the prevention of gastric cancer." Digestion, vol. 74, no. 3-4, 2006, pp. 184-6. |
| Zhang Y, Cristofaro P, Silbermann R, Pusch O, Boden D, Konkin T, Hovanesian V, Monfils PR, Resnick M, Moss SF, Ramratnam B. "Engineering mucosal RNA interference in vivo." Molecular therapy : the journal of the American Society of Gene Therapy, vol. 14, no. 3, 2006, pp. 336-42. |
| Resnick MB, Sabo E, Meitner PA, Kim SS, Cho Y, Kim HK, Tavares R, Moss SF. "Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo." Gut, vol. 55, no. 12, 2006, pp. 1717-24. |
| Shirin H, Moss SF, Kancherla S, Kancherla K, Holt PR, Weinstein IB, Sordillo EM. "Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori." Journal of gastroenterology and hepatology, vol. 21, no. 9, 2006, pp. 1388-93. |
| Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA. "Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression." Aliment Pharmacol Ther, vol. 23, no. 6, 2006, pp. 683-90. |
| Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt DE, Sabo E, Moss SF. "Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation." Human Pathology, vol. 36, no. 8, 2005, pp. 886-92. |
| Kethu SR, Davis GC, Reinert SE, Ramzan UC, Moss SF. "Low utility of endoscopy for suspected upper gastrointestinal bleeding occurring in hospitalized patients." Southern Medical Journal, vol. 98, no. 2, 2005, pp. 170-5. |
| Moss SF, Blaser MJ. "Mechanisms of disease: Inflammation and the origins of cancer." Nature clinical practice. Oncology, vol. 2, no. 2, 2005, pp. 90-7; quiz 1 p following 113. |
| Kuzushita N, Rogers AB, Monti NA, Whary MT, Park MJ, Aswad BI, Shirin H, Koff A, Eguchi H, Moss SF. "p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice." Gastroenterology, vol. 129, no. 5, 2005, pp. 1544-56. |
| Shirin H, Kravtsov V, Shahmurov M, Petchenko P, Boaz M, Moss SF, Avni Y, Avinoach I. "p27kip1 expression is inversely related to the grade of gastric MALT lymphoma." International journal of gastrointestinal cancer, vol. 35, no. 1, 2005, pp. 25-32. |
| Modlin IM, Moss SF, Kidd M, Lye KD. "Gastroesophageal reflux disease: then and now." Journal of clinical gastroenterology, vol. 38, no. 5, 2004, pp. 390-402. |
| Levine A, Shevah O, Shabat-Sehayek V, Aeed H, Boaz M, Moss SF, Niv Y, Avni Y, Shirin H. "Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole." Aliment Pharmacol Ther, vol. 20, no. 1, 2004, pp. 117-22. |
| Eguchi H, Carpentier S, Kim SS, Moss SF. "P27kip1 regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori." Gut, vol. 53, no. 6, 2004, pp. 797-804. |
| Shirin H, Sadan O, Shevah O, Bruck R, Boaz M, Moss SF, Everon S, Glezerman M, Avni Y. "Positive serology for Helicobacter pylori and vomiting in the pregnancy." Archives of gynecology and obstetrics, vol. 270, no. 1, 2004, pp. 10-4. |
| Xu H, Chaturvedi R, Cheng Y, Bussiere FI, Asim M, Yao MD, Potosky D, Meltzer SJ, Rhee JG, Kim SS, Moss SF, Hacker A, Wang Y, Casero RA Jr, Wilson KT. "Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis." Cancer Research, vol. 64, no. 23, 2004, pp. 8521-5. |
| Shirin H, Frenkel D, Shevah O, Levine A, Bruck R, Moss SF, Niv Y, Avni Y. "Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test." American Journal of Gastroenterology, vol. 98, no. 1, 2003, pp. 46-50. |
| Moss SF, Armstrong D, Arnold R, Ferenci P, Fock KM, Holtmann G, McCarthy DM, Moraes-Filho JP, Mutschler E, Playford R, Spechler SJ, Stanghellini V, Modlin IM. "GERD 2003 -- a consensus on the way ahead." Digestion, vol. 67, no. 3, 2003, pp. 111-7. |
| Eguchi H, Herschenhous N, Kuzushita N, Moss SF. "Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells." Cancer Research, vol. 63, no. 15, 2003, pp. 4739-46. |
| Moss SF, Sood S. "Helicobacter pylori." Current opinion in infectious diseases, vol. 16, no. 5, 2003, pp. 445-51. |
| Shirin H, Pinto JT, Moss SF. "Influence of clinical factors, drug use, and food intake on the glutathione system." Gut, vol. 52, no. 1, 2003, pp. 154; author reply 154-5. |
| Shirin H, Hibshoosh H, Kawabata Y, Weinstein IB, Moss SF. "p16Ink4a is overexpressed in H. pylori-associated gastritis and is correlated with increased epithelial apoptosis." Helicobacter, vol. 8, no. 1, 2003, pp. 66-71. |
| Moss SF. "RUNX 3, apoptosis 0: a new gastric tumour suppressor." Gut, vol. 52, no. 1, 2003, pp. 12-3. |
| Holt PR, Arber N, Halmos B, Forde K, Kissileff H, McGlynn KA, Moss SF, Kurihara N, Fan K, Yang K, Lipkin M. "Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D." Cancer Epidemiology Biomarkers & Prevention, vol. 11, no. 1, 2002, pp. 113-9. |
| Sordillo EM, Moss SF. "Helicobacter pylori and apoptosis." Methods in enzymology, vol. 358, 2002, pp. 319-34. |
| Eid R, Moss SF. "Helicobacter pylori infection and the development of gastric cancer." New England Journal of Medicine, vol. 346, no. 1, 2002, pp. 65-7. |
| Eguchi H, Moss SF. "Helicobacter pylori." Molecular pathology : MP, vol. 55, no. 5, 2002, pp. 284-5. |
| Moss SF, Modlin IM. "Summation: irritable bowel and the irritable physician." Journal of clinical gastroenterology, vol. 35, no. 1 Suppl, 2002, pp. S68-70. |
| Shirin H, Pinto JT, Kawabata Y, Soh JW, Delohery T, Moss SF, Murty V, Rivlin RS, Holt PR, Weinstein IB. "Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide." Cancer Research, vol. 61, no. 2, 2001, pp. 725-31. |
| Holt PR, Wolper C, Moss SF, Yang K, Lipkin M. "Comparison of calcium supplementation or low-fat dairy foods on epithelial cell proliferation and differentiation." Nutrition and Cancer, vol. 41, no. 1-2, 2001, pp. 150-5. |
| Morgenstern S, Koren R, Moss SF, Fraser G, Okon E, Niv Y. "Does Helicobacter pylori affect gastric mucin expression? Relationship between gastric antral mucin expression and H. pylori colonization." European Journal of Gastroenterology & Hepatology, vol. 13, no. 1, 2001, pp. 19-23. |
| Marchbank T, Cox HM, Goodlad RA, Giraud AS, Moss SF, Poulsom R, Wright NA, Jankowski J, Playford RJ. "Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice." Journal of Biological Chemistry, vol. 276, no. 26, 2001, pp. 24088-96. |
| Shirin H, Weinstein IB, Moss SF. "Effects of H. pylori infection of gastric epithelial cells on cell cycle control." Frontiers in Bioscience, vol. 6, 2001, pp. E104-18. |
| Shirin H, Kenet G, Shevah O, Wardi J, Birkenfeld S, Shahmurov M, Bruck R, Niv Y, Moss SF, Avni Y. "Evaluation of a novel continuous real time (13)C urea breath analyser for Helicobacter pylori." Aliment Pharmacol Ther, vol. 15, no. 3, 2001, pp. 389-94. |
| Shirin H, Pinto JT, Liu LU, Merzianu M, Sordillo EM, Moss SF. "Helicobacter pylori decreases gastric mucosal glutathione." Cancer Letters, vol. 164, no. 2, 2001, pp. 127-33. |
| Israel DA, Salama N, Arnold CN, Moss SF, Ando T, Wirth HP, Tham KT, Camorlinga M, Blaser MJ, Falkow S, Peek RM Jr. "Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses." Journal of Clinical Investigation, vol. 107, no. 5, 2001, pp. 611-20. |
| Moss SF, Sordillo EM, Abdalla AM, Makarov V, Hanzely Z, Perez-Perez GI, Blaser MJ, Holt PR. "Increased gastric epithelial cell apoptosis associated with colonization with cagA + Helicobacter pylori strains." Cancer Research, vol. 61, no. 4, 2001, pp. 1406-11. |
| Shirin H, Sordillo EM, Kolevska TK, Hibshoosh H, Kawabata Y, Oh SH, Kuebler JF, Delohery T, Weghorst CM, Weinstein IB, Moss SF. "Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1)." Infection and Immunity, vol. 68, no. 9, 2000, pp. 5321-8. |
| Kidd M, Tang LH, Modlin IM, Zhang T, Chin K, Holt PR, Moss SF. "Gastrin-mediated alterations in gastric epithelial apoptosis and proliferation in a mastomys rodent model of gastric neoplasia." Digestion, vol. 62, no. 2-3, 2000, pp. 143-51. |
| Peek RM Jr, Wirth HP, Moss SF, Yang M, Abdalla AM, Tham KT, Zhang T, Tang LH, Modlin IM, Blaser MJ. "Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils." Gastroenterology, vol. 118, no. 1, 2000, pp. 48-59. |
| Shirin H, Moss SF. "A key cytokine unlocks the door." Gut, vol. 45, no. 1, 1999, pp. 5-6. |
| Moss SF, Krivosheyev V, de Souza A, Chin K, Gaetz HP, Chaudhary N, Worman HJ, Holt PR. "Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms." Gut, vol. 45, no. 5, 1999, pp. 723-9. |
| Moss SF, Valle J, Abdalla AM, Wang S, Siurala M, Sipponen P. "Gastric cellular turnover and the development of atrophy after 31 years of follow-up: a case-control study." American Journal of Gastroenterology, vol. 94, no. 8, 1999, pp. 2109-14. |
| Shirin H, Sordillo EM, Oh SH, Yamamoto H, Delohery T, Weinstein IB, Moss SF. "Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells." Cancer Research, vol. 59, no. 10, 1999, pp. 2277-81. |
| Liu LU, Holt PR, Krivosheyev V, Moss SF. "Human right and left colon differ in epithelial cell apoptosis and in expression of Bak, a pro-apoptotic Bcl-2 homologue." Gut, vol. 45, no. 1, 1999, pp. 45-50. |
| Shirin H, Dotan I, Papa M, Maaravi Y, Aeed H, Zaidel L, Matas Z, Bruck R, Moss SF, Halpern Z, Oren R. "Inhibition of concanavalin A-induced acute T cell dependent hepatic damage in mice by hypothyroidism." Liver, vol. 19, no. 3, 1999, pp. 206-11. |
| Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR. "Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells." Clin Cancer Res , vol. 5, no. 8, 1999, pp. 2223-9. |
| Oren R, Dabeva MD, Karnezis AN, Petkov PM, Rosencrantz R, Sandhu JP, Moss SF, Wang S, Hurston E, Laconi E, Holt PR, Thung SN, Zhu L, Shafritz DA. "Role of thyroid hormone in stimulating liver repopulation in the rat by transplanted hepatocytes." Hepatology, vol. 30, no. 4, 1999, pp. 903-13. |
| Moss SF. "The carcinogenic effect of H. pylori on the gastric epithelial cell." Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, vol. 50, no. 5, 1999, pp. 847-56. |
| Moss SF, Arnold R, Tytgat GN, Spechler SJ, Delle-Fave G, Rosin D, Jensen RT, Modlin IM. "Consensus Statement for Management of Gastroesophageal Reflux Disease: result of workshop meeting at Yale University School of Medicine, Department of Surgery, November 16 and 17, 1997." Journal of clinical gastroenterology, vol. 27, no. 1, 1998, pp. 6-12. |
| Holt PR, Moss SF, Heydari AR, Richardson A. "Diet restriction increases apoptosis in the gut of aging rats." The Journals of Gerontology: Series A, vol. 53, no. 3, 1998, pp. B168-72. |
| Moss SF. "Helicobacter pylori and apoptosis--is there consensus?." Italian journal of gastroenterology and hepatology, vol. 30, no. 2, 1998, pp. 160-1. |
| Moss SF. "Helicobacter pylori and apoptosis." The Yale journal of biology and medicine, vol. 71, no. 2, 1998, pp. 53-61. |
| Shirin H, Moss SF. "Helicobacter pylori induced apoptosis." Gut, vol. 43, no. 5, 1998, pp. 592-4. |
| Moss SF, Fendrick AM, Cave DR, Modlin IM. "Helicobacter pylori--more light, less heat." American Journal of Gastroenterology, vol. 93, no. 3, 1998, pp. 306-10. |
| Abdalla AM, Sordillo EM, Hanzely Z, Perez-Perez GI, Blaser MJ, Holt PR, Moss SF. "Insensitivity of the CLOtest for H. pylori, especially in the elderly." Gastroenterology, vol. 115, no. 1, 1998, pp. 243-4. |
| Holt PR, Atillasoy EO, Gilman J, Guss J, Moss SF, Newmark H, Fan K, Yang K, Lipkin M. "Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial." JAMA, vol. 280, no. 12, 1998, pp. 1074-9. |
| Moss SF. "Review article: Cellular markers in the gastric precancerous process." Aliment Pharmacol Ther, vol. 12 Suppl 1, 1998, pp. 91-109. |
| Chen G, Sordillo EM, Ramey WG, Reidy J, Holt PR, Krajewski S, Reed JC, Blaser MJ, Moss SF. "Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of BAK." Biochemical and Biophysical Research Communications, vol. 239, no. 2, 1997, pp. 626-32. |
| Peek RM Jr, Moss SF, Tham KT, Pérez-Pérez GI, Wang S, Miller GG, Atherton JC, Holt PR, Blaser MJ. "Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis." JNCI Journal of the National Cancer Institute, vol. 89, no. 12, 1997, pp. 863-8. |
| Holt PR, Moss SF, Kapetanakis AM, Petrotos A, Wang S. "Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen?." Cancer Epidemiology Biomarkers & Prevention, vol. 6, no. 2, 1997, pp. 131-5. |
| Guan RJ, Moss SF, Arber N, Krajewski S, Reed JC, Holt PR. "30 KDa phosphorylated form of Bcl-2 protein in human colon." Oncogene, vol. 12, no. 12, 1996, pp. 2605-9. |
| Moss SF, Scholes JV, Holt PR. "Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling." Digestive Diseases and Sciences, vol. 41, no. 11, 1996, pp. 2238-47. |
| Moss SF, Holt PR. "Apoptosis in the intestine." Gastroenterology, vol. 111, no. 2, 1996, pp. 567-8. |
| Holt PR, Atillasoy E, Lindenbaum J, Ho SB, Lupton JR, McMahon D, Moss SF. "Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices." Metabolism: clinical and experimental, vol. 45, no. 9, 1996, pp. 1179-87. |
| Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. "Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas." Cancer Research, vol. 56, no. 10, 1996, pp. 2422-7. |
| Holt PR, Moss SF, Whelan R, Guss J, Gilman J, Lipkin M. "Fecal and rectal mucosal diacylglycerol concentrations and epithelial proliferative kinetics." Cancer Epidemiology Biomarkers & Prevention, vol. 5, no. 11, 1996, pp. 937-40. |
| Sutter T, Arber N, Moss SF, Findling RI, Neugut AI, Weinstein IB, Holt PR. "Frequent K-ras mutations in small bowel adenocarcinomas." Digestive Diseases and Sciences, vol. 41, no. 1, 1996, pp. 115-8. |
| Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR. "Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis." Gastroenterology, vol. 110, no. 3, 1996, pp. 669-74. |
| Moss SF, Agarwal B, Arber N, Guan RJ, Krajewska M, Krajewski S, Reed JC, Holt PR. "Increased intestinal Bak expression results in apoptosis." Biochemical and Biophysical Research Communications, vol. 223, no. 1, 1996, pp. 199-203. |
| Moss SF, Attia L, Scholes JV, Walters JR, Holt PR. "Increased small intestinal apoptosis in coeliac disease." Gut, vol. 39, no. 6, 1996, pp. 811-7. |
| Moss SF, Calam J, Agarwal B, Wang S, Holt PR. "Induction of gastric epithelial apoptosis by Helicobacter pylori." Gut, vol. 38, no. 4, 1996, pp. 498-501. |
| Moss SF, Liu TC, Petrotos A, Hsu TM, Gold LI, Holt PR. "Inward growth of colonic adenomatous polyps." Gastroenterology, vol. 111, no. 6, 1996, pp. 1425-32. |
| Moss SF, Wright NA. "Molecular aspects of mucosal repair: a summary." The Yale journal of biology and medicine, vol. 69, no. 2, 1996, pp. 155-8. |
| Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA. "Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association." JNCI Journal of the National Cancer Institute, vol. 87, no. 10, 1995, pp. 762-3. |
| Moss SF, Calam J. "Acid hypersecretion in duodenal ulcer patients." American Journal of Gastroenterology, vol. 89, no. 9, 1994, pp. 1598-9. |
| Moss SF, Legon S, Davies J, Calam J. "Cytokine gene expression in Helicobacter pylori associated antral gastritis." Gut, vol. 35, no. 11, 1994, pp. 1567-70. |
| Moss SF, Legon S, Calam J. "Reciprocal changes in antral gastrin and somatostatin mRNA in pernicious anemia." Digestive Diseases and Sciences, vol. 39, no. 2, 1994, pp. 321-6. |
| Moss SF, Calam J. "Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori." Gut, vol. 34, no. 7, 1993, pp. 888-92. |
| Lacey SL, Moss SF, Taylor GW. "Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori." Journal of Antimicrobial Chemotherapy, vol. 32, no. 3, 1993, pp. 393-400. |
| Moss SF, Lehner PJ, Gilbey SG, Kennedy A, Hughes JM, Bloom SR, Hodgson HJ. "Pleural involvement in the carcinoid syndrome." The Quarterly journal of medicine, vol. 86, no. 1, 1993, pp. 49-53. |
| Moss SF, Waheed A, Beardshall K, Gill J, Adamson D, Unwin R, Calam J. "Use of endoscopic biopsies and microelectrodes to study human gastric acid secretion in vitro." Neuropeptides, vol. 25, no. 4, 1993, pp. 265-9. |
| Butcher GP, Zambon M, Moss S, Walters JR. "Addisonian crisis presenting with a normal short tetracosactrin stimulation test." Postgraduate medical journal, vol. 68, no. 800, 1992, pp. 465-6. |
| Moss SF, Legon S, Bishop AE, Polak JM, Calam J. "Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease." The Lancet, vol. 340, no. 8825, 1992, pp. 930-2. |
| Moss SF, Ghosh P, Thomas DM, Jackson JE, Calam J. "Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone." Gut, vol. 33, no. 5, 1992, pp. 715-7. |
| Moss SF, Thomas DM, Mulnier C, McGill IG, Hodgson HJ. "Intestinal lymphangiectasia associated with angiofollicular lymph node hyperplasia (Castleman's disease)." Gut, vol. 33, no. 1, 1992, pp. 135-7. |
| Moss SF, Playford RJ, Ayesu K, Li SK, Calam J. "pH-dependent secretion of gastrin in duodenal ulcer disease: effect of suppressing Helicobacter pylori." Digestion, vol. 52, no. 3-4, 1992, pp. 173-8. |
| Moss SF, Thomas DM, Ayesu K, Levi S, Calam J. "Sucralfate diminishes basal acid output without affecting gastrin, H. pylori or gastritis in duodenal ulcer patients." Aliment Pharmacol Ther, vol. 6, no. 2, 1992, pp. 251-8. |
| Beardshall K, Moss S, Gill J, Levi S, Ghosh P, Playford RJ, Calam J. "Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients." Gut, vol. 33, no. 5, 1992, pp. 601-3. |
| Moss SF, Ind PW. "Time course of recovery of lung function in sulphasalazine-induced alveolitis." Respiratory Medicine, vol. 85, no. 1, 1991, pp. 73-5. |
| Moss SF, Walters JR, Tonge KA. "Cholestasis associated with cinnarizine." BMJ, vol. 301, no. 6763, 1990, pp. 1281. |
| Moss SF, Ind PW. "Ethnic differences in consultation rates." BMJ, vol. 300, no. 6716, 1990, pp. 47. |
| Moss SF, Currie DC, Sheffield EA, Baxter M, Corrin B, Evans TW. "Abnormal lung lymphatics and respiratory failure." Thorax, vol. 44, no. 5, 1989, pp. 432-3. |
| Year | Degree | Institution |
|---|---|---|
| 1985 | MD | University College London |
| 1982 | BSc | University College London |
| Fellow | St. Luke's-Roosevelt Hospital Center, gastroenterology | 1993-1995 | NY |
| Clinical Fellow; Research Fellow | Royal Postgraduate Medical School, Hammersmith Hospital, gastroenterology | 1990-1993 | London, UK |
| Resident | Central Middlesex Hospital; Royal Brompton Hospital; Charing Cross Hospital; Ealing Hospital, medicine | 1986-1990 | London, UK |
| Intern | house physician | 1985-1986 | London, UK |
| Intern | house surgeon | 1985-1986 | London, UK |
Wellcome Trust Research Fellow, 1991-3
Glaxo-Wellcome Basic Research Awards, 1997-8 and 1998-9.
American Gastroenterology Association, Funderburg Award for Gastric Cancer Research, 2002
Consultant to WHO (International Agency for Research on Cancer) on role of H. pylori in human gastric carcinogenesis agents. Lyon, France, Feb 2009.
Chair of the Brown Medical Faculty Executive Committee, 2018-2019
Chair of the EGD section of the AGA Council, responsible for programming Digestive diseases Week, 2019-2023
Member of the "Masstricht" International Consortium on H. pylori management
Served on the Editorial Boards of Gastroenterology, American Jounal of Gastroenterology, Gut, Alimentary Pharmacology & Therapeutics and Helicobacter
| Name | Title |
|---|---|
| D'Agata, Erika | Professor of Medicine |
| Resnick, Murray | Professor of Pathology and Laboratory Medicine |
| Medical License | Rhode Island | 2000-Present | |
| Certification | American Board of Internal Medicine, Gastroenterology | 1998- | |
| Certification | American Board of Internal Medicine, Internal medicine | 1996- | |
| Medical License | New York | 1993-2000 | |
| Medical License | UK | 1985- |
| Director of Endoscopy; Staff Gastroenterologist. Providence VA Medical Center, 2011-Present |
| Consultant Gastroenterologist. Providence VA Medical Center, 2006-2011 |
| Director. GI Fellowship Training Program, Brown University Affiliated Program, 2006-2026 |
| Associate Director. GI Fellowship Training Program, Brown University Affiliated Program, 2002-2006 |
| Attending Physician. Rhode Island Hospital, 2000-Present |
| Attending Physician. St. Luke's-Roosevelt Hospital Center, 1995-2000 |
